CBT vs PATH
Cabot Corporation (CBT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. Revenue was down 7.0% from 2024-09-30 to 2025-09-30. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CBT and PATH stock pages for the full models.
Not investment advice.